Investment Thesis
Precipio exhibits structurally weak fundamentals with negative operating margins (-21.3%), declining revenue (-0.8% YoY), and negligible free cash flow ($14K on $6.7M revenue). While YoY improvement suggests turnaround momentum and balance sheet strength provides near-term runway, the company remains unprofitable with no clear path to sustainable operations at current scale.
Strengths
- Strong balance sheet with minimal debt (Debt/Equity 0.00x, only $40K long-term debt)
- Significant YoY improvement in net income (+91.5%) and EPS (+92.2%) indicating turnaround trajectory
- Reasonable gross margin of 40.6% suggesting viable product value proposition
- Adequate liquidity with 1.56x current ratio supporting near-term operations
Risks
- Currently unprofitable with -$1.4M operating loss and -21.5% net margin
- Revenue declining (-0.8% YoY) with no growth momentum in $6.7M revenue base
- Critically weak free cash flow generation at $14K (0.2% FCF margin) despite scale
- Very small company with limited resources and operational leverage in competitive laboratory instruments sector
- Operating cash flow of $64K barely covers capex, indicating minimal organic funding capacity
Key Metrics to Watch
- Revenue growth rate - must achieve positive YoY growth for viability
- Operating margin trajectory - path to positive operating income at current or expanded revenue
- Free cash flow generation - sustainability and conversion rate vs. operating income
Financial Metrics
Revenue
6.7M
Net Income
-1.4M
EPS (Diluted)
$-0.81
Free Cash Flow
14.0K
Total Assets
20.8M
Cash
2.6M
Profitability Ratios
Gross Margin
40.6%
Operating Margin
-21.3%
Net Margin
-21.5%
ROE
-10.2%
ROA
-6.9%
FCF Margin
0.2%
Balance Sheet & Liquidity
Current Ratio
1.56x
Quick Ratio
1.33x
Debt/Equity
0.00x
Debt/Assets
31.9%
Interest Coverage
N/A
Long-term Debt
40.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-15T10:02:36.857314 |
Data as of: 2026-03-31 |
Powered by Claude AI